COPD Foundation Expresses Concern Over FDA's Rescission of Marketing Denial Orders for JUUL Products
June 22, 2024
June 22, 2024
MIAMI, Florida, June 22 -- The COPD Foundation issued the following news release:
The COPD Foundation has expressed concerns following the U.S. Food and Drug Administration's (FDA) decision to rescind the marketing denial orders (MDOs) previously issued to JUUL Labs, Inc. The Foundation emphasizes the importance of protecting youth from the potential harms of e-cigarettes while recognizing the use of these products for adult smokers aiming to quit traditional cigarettes.
The COPD Foundation has expressed concerns following the U.S. Food and Drug Administration's (FDA) decision to rescind the marketing denial orders (MDOs) previously issued to JUUL Labs, Inc. The Foundation emphasizes the importance of protecting youth from the potential harms of e-cigarettes while recognizing the use of these products for adult smokers aiming to quit traditional cigarettes.